GLRX and chronic myelogenous leukemia, BCR-ABL1 positive: We show that oncogenic activation of STAT5 induced by Bcr-Abl in CML cells enhances ROS levels through the repression of catalase and glutaredoxin-1 (Glrx1), two enzymes involved in antioxidant defenses.